The first computer algorithm capable of identifying which tumor cells are driving aggressive cancer growth has been developed ...

The first computer algorithm capable of identifying which tumor cells are driving aggressive cancer growth has been developed by Cancer Research UK-funded scientists from UCL and The Francis Crick ...

Merck & Co., Inc. (MRK) announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...

Merck ( MRK, Financials) stated that sacituzumab tirumotecan (sac-TMT) was designated a Breakthrough Therapy by the FDA for advanced or metastatic nonsquamous non-small cell lung cancer with epidermal ...

Apollo Cancer Centre launches LungLife Screening Programme for early detection of lung cancer using LDCT technology.

The FDA has granted Breakthrough Therapy designation to sacituzumab tirumotecan for patients with advanced or metastatic ...

Luye Pharma Group (HK:2186) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - ...

In recognition of their innovative cancer research, two scientists at the University of Texas Health Science Center at San ...

Join us to explore the latest insights into the future of precision oncology! This year, the Agilent Precision Oncology ...

Merck's (MRK) antibody drug conjugate sac-TMT has received FDA Breakthrough Therapy designation for the treatment of EGFR-mutated lung cancer. Read more here.

The company will evaluate the Hepzato kit as a combination therapy with the standard of care in patients with liver-dominant ...

A study from the University of Michigan Health Rogel Cancer Center may have—at last—cracked the cold case of immunotherapy ...